1st International Course on
Integrated Biomarkers

Biochemical and Bioimaging Endpoints in Cardiocerebrovascular Diagnosis,

Prevention, Therapy and Drug Development

Lugano (Switzerland), October 27-29, 2005


A. Peracino's curriculum vitae

Dr. Peracino is the Senior Medical Advisor of the G. Lorenzini Medical Foundation (Milan-Houston) from 2005. He received his MD Degree Magna cum Laude in Medicine and Surgery from the University of Turin in 1959, and completed his Internship at the Department of Histopathology, University of Turin (1959 -1964). He received his Post-doctoral Speciality Degree in Dermatology, University of Bologna, in 1962; Post-doctoral Speciality Degree in Forensic Medicine, University of Bologna in 1966; Post-doctoral Speciality Degree in Pathology and Biochemistry, University of Parma in 1969.

In 1964-1967 Dr. Peracino was appointed Associate Director, Clinical and Forensic Pathology & Laboratory Medicine, General Hospital, Rimini; in 1967-1969 he became Associate Director, Clinical and Forensic Pathology & Laboratory medicine, and Acting Director, Clinical and Forensic Pathology & Laboratory Medicine, General Hospital, Ancona in 1969-1972. In 1972-1973 Dr. Peracino became Director, Clinical Pathology & Laboratory Medicine, General Hospital, Morbegno; in 1974-1977 Medical Director, and in 1973-1977 Director, Clinical Pathology & Laboratory Medicine , General Hospital, Treviglio. In 1977 he moved to the Scientific Institute San Raffaele, Milan where he acted as Director, Laboratory Medicine, and in 1981 as Medical Director.

Dr. Peracino became then General Manager, Istituto Behring SpA in 1981-1988; responsible for Special Projects, Hoechst AG, Frankfurt, Deutschland in 1983-1985; Marketing Director, Hoechst UK Ltd, Hounslow, Great Britain in 1986-1988; Chairman of the Board, Istituto Behring SpA and Chairman of Pharmaceutical Sector, Hoechst Italia SpA in 19988-1994. In 1996-1998, Dr. Peracino was appointed Chairman of the Board, Gruppo Lepetit SpA.
In 1994-1997, Dr. Peracino was elected President, Istituto Behring SpA; Vice President, Hoechst Marion Roussel SpA in 1995-1998; President, Hoechst Farmaceutici SpA in 1994-1998; and President, Hoechst Foundation in 1994-1998.
Dr. Peracino is member of the Board, Italian Society of Pharmaceutical Sciences from 1995; Ausichtsratmitglieder, Brahms AG (Berlin) from 1998; Vice President, Italian Heart Foundation from 2003; Member of Scientific Committee, G. Lorenzini Medical Foundation (Milan-Houston) from 2004.

Dr. Peracino main fields of experience are Histopathology, Immunechemistry, Laboratory Management & Automation, Forensic Medicine, Molecular Medicine, Infections, Diabetes, Informatics, Cyber Communication, Hospital Organization & Management, Health Economics. In 1973, in collaboration with Olivetti SpA developed the first software for Clinical Laboratory management. In 1975, organised a Scientific Expedition to study the African Pigmies in Rwanda. In 1979 he holds a Patent in development of a Clinical Chemistry System.
Dr. Peracino from 1967 to 1981 has been visiting Scientist in Major Academic and Scientific Institutions in Denmark, Finland, France, UK, USA.
Dr. Peracino is author and Co-author of over 150 scientific publications in addition to books, book chapters and review articles, websites and web journals commentaries and editorial activities.

Dr Peracino since 1998 took active part in numerous projects, such as ENHE : European Network of Hospitals for Excellence; SEFAP: Service for Farmacoprevention and Farmacovigilance; NORT: feasibility Plan for a network of Hospitals in Trento area; BRAHMS Italia: a new Company in Scientific Communication and Biotechnology in Italy; TRE - LAB 2000: Laboratory Medicine Department in the multi-centre Hospital of Treviglio; ORT: Strategic and Organizational Plans of Ospedali Riuniti di Treviglio; H-ospital: a portal for a health economics human oriented hospital; TM: hospitals network for tele-medicine and e-learning in Italy; National campaign on Primary and Secondary Prevention of the Global Cardiovascular Risk; Assr: guide lines, policies and management operations in high technology hospitals; DR: strategic reengineering integrated project for highly technological diagnostic and research laboratory; Bioniniziativa: scouting on industrial opportunities in Biotechnology Research Centres in Lombardy; SIPrEM: founder of the Italian Society for the Prevention of Error in Medicine.